TY - JOUR
T1 - Innovations in human immunodeficiency virus (HIV) care delivery during the coronavirus disease 2019 (COVID-19) Pandemic
T2 - Policies to strengthen the ending the epidemic initiative - A policy paper of the infectious diseases society of America and the HIV medicine association
AU - Armstrong, Wendy S.
AU - Agwu, Allison L.
AU - Barrette, Ernie Paul
AU - Ignacio, Rachel Bender
AU - Chang, Jennifer J.
AU - Colasanti, Jonathan A.
AU - Floris-Moore, Michelle
AU - Haddad, Marwan
AU - Maclaren, Lynsay
AU - Weddle, Andrea
N1 - Publisher Copyright:
© 2020 The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].
PY - 2021/1/1
Y1 - 2021/1/1
N2 - The goal of the Ending the HIV Epidemic Initiative is to reduce new infections in the United States by 90% by 2030. Success will require fundamentally changing human immunodeficiency virus (HIV) prevention and care delivery to engage more persons with HIV and at risk of HIV in treatment. While the coronavirus disease 2019 (COVID-19) pandemic reduced in-person visits to care facilities and led to concern about interruptions in care, it also accelerated growth of alternative options, bolstered by additional funding support. These included the use of telehealth, medication delivery to the home, and increased flexibility facilitating access to Ryan White HIV/AIDS Program services. While the outcomes of these programs must be studied, many have improved accessibility during the pandemic. As the pandemic wanes, long-term policy changes are needed to preserve these options for those who benefit from them. These new care paradigms may provide a roadmap for progress for those with other chronic health issues as well.
AB - The goal of the Ending the HIV Epidemic Initiative is to reduce new infections in the United States by 90% by 2030. Success will require fundamentally changing human immunodeficiency virus (HIV) prevention and care delivery to engage more persons with HIV and at risk of HIV in treatment. While the coronavirus disease 2019 (COVID-19) pandemic reduced in-person visits to care facilities and led to concern about interruptions in care, it also accelerated growth of alternative options, bolstered by additional funding support. These included the use of telehealth, medication delivery to the home, and increased flexibility facilitating access to Ryan White HIV/AIDS Program services. While the outcomes of these programs must be studied, many have improved accessibility during the pandemic. As the pandemic wanes, long-term policy changes are needed to preserve these options for those who benefit from them. These new care paradigms may provide a roadmap for progress for those with other chronic health issues as well.
KW - HIV
KW - Ryan White HIV/AIDS Program
KW - antiretroviral therapy
KW - pre-exposure prophylaxis
KW - telehealth
UR - http://www.scopus.com/inward/record.url?scp=85099401440&partnerID=8YFLogxK
U2 - 10.1093/cid/ciaa1532
DO - 10.1093/cid/ciaa1532
M3 - Article
C2 - 33035296
AN - SCOPUS:85099401440
SN - 1058-4838
VL - 72
SP - 9
EP - 14
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 1
ER -